|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.28 0.00 (0.00%) as of 4:30 Tue 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
28,430,000 |
| Market
Cap: |
7.96(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.2799 - $0.2799 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ElectroCore is a commercial stage medical device company with a non-invasive vagus nerve stimulation (nVNS) therapy, called gammaCore. nVNS is a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. Co.'s gammaCore therapy is prescription-only, with patients self-administering discrete doses using a handheld unit. Co.'s primary model, gammaCore Sapphire is a portable, reusable, rechargeable and reloadable option for patients, with the prescription being written by a health care provider and dispensed from a specialty pharmacy or fulfilled from its facility in Rockaway, NJ.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
16,000 |
118,491 |
1,219,199 |
| Total Buy Value |
$0 |
$0 |
$230,144 |
$599,976 |
| Total People Bought |
0 |
1 |
2 |
6 |
| Total Buy Transactions |
0 |
1 |
4 |
31 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Errico Thomas J. |
Director |
– • – |
2019-08-16 |
4 |
B |
$1.62 |
$30,738 |
D/D |
18,974 |
883,237 |
2.39 |
- |
|
| Tullis James L L |
Director |
– • – |
2019-08-16 |
4 |
B |
$1.64 |
$78,085 |
D/D |
47,613 |
158,840 |
2.39 |
- |
|
| Core Ventures Ii, Llc |
10% Owner |
– – • |
2019-06-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,697,813) |
1,802,836 |
|
- |
|
| Errico Thomas J. |
Director |
– • • |
2019-06-07 |
4 |
B |
$1.77 |
$12,358 |
D/D |
7,000 |
484,651 |
3.92 |
- |
|
| Cox Carrie Smith |
Director |
– • – |
2019-06-06 |
4 |
B |
$1.82 |
$18,200 |
D/D |
10,000 |
21,000 |
2.39 |
- |
|
| Errico Thomas J. |
Director |
– • • |
2019-06-06 |
4 |
B |
$1.64 |
$37,139 |
D/D |
21,000 |
477,651 |
3.92 |
- |
|
| Posner Brian M |
Chief Financial Officer |
• – – |
2019-06-06 |
4 |
B |
$1.72 |
$17,225 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-04-12 |
4 |
AS |
$5.53 |
$143,056 |
D/D |
(25,869) |
532,349 |
|
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-04-11 |
4 |
AS |
$5.49 |
$75,339 |
D/D |
(13,723) |
558,218 |
|
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-04-01 |
4 |
AS |
$6.97 |
$72,544 |
D/D |
(10,408) |
571,941 |
|
- |
|
| Staats Peter S. |
Chief Medical Officer |
• – – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,976 |
163,612 |
|
- |
|
| Vraniak Glenn S. |
Chief Financial Officer |
• – – |
2019-03-22 |
4 |
A |
$8.40 |
$24,998 |
D/D |
2,976 |
120,811 |
|
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-01-17 |
4 |
AS |
$4.84 |
$37,950 |
D/D |
(7,841) |
582,349 |
|
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-01-16 |
4 |
AS |
$4.89 |
$96,871 |
D/D |
(19,810) |
590,190 |
|
- |
|
| Errico Joseph P |
See Remarks |
• • • |
2019-01-15 |
4 |
AS |
$4.90 |
$109,510 |
D/D |
(22,349) |
610,000 |
|
- |
|
| Core Ventures Ii, Llc |
10% Owner |
– – • |
2019-01-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,232,056) |
6,500,649 |
|
- |
|
| Staats Peter S. |
Chief Medical Officer |
• – – |
2018-12-13 |
4 |
B |
$4.83 |
$48,300 |
D/D |
10,000 |
154,636 |
2.74 |
- |
|
| Amato Francis R. |
Chief Executive Officer |
• • – |
2018-12-06 |
4 |
B |
$6.53 |
$49,009 |
D/D |
7,500 |
358,831 |
2.81 |
- |
|
| Cox Carrie Smith |
Director |
– • – |
2018-12-03 |
4 |
B |
$6.78 |
$49,587 |
D/D |
7,300 |
11,000 |
2.39 |
- |
|
| Cox Carrie Smith |
Director |
– • – |
2018-08-17 |
4 |
B |
$13.76 |
$50,919 |
D/D |
3,700 |
17,033 |
2.39 |
- |
|
| Merck Global Health Innovation Fund, Llc |
10% Owner |
– – • |
2018-06-21 |
4 |
B |
$15.00 |
$2,499,990 |
D/D |
166,666 |
3,346,032 |
2.45 |
- |
|
96 Records found
|
|
Page 4 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
